NYSE: UNH · Healthcare Plans
UnitedHealth Group (UNH) fair value: undervalued or overvalued?
As of 14 Nov 2026, Faircurve's model values UnitedHealth Group (UNH) at $405.70 a share. The stock last closed at $412.02, which puts the model's fair value 1.5% below the price. On the model's bands that reads as Fairly valued.
Revalued . Price is the close of 16 Nov 2026. UnitedHealth Group Incorporated.
The report adds the live price, the chart against the range the options market prices, the next earnings date and the analysts' consensus. No account needed.
This week, in three parts
What happenedThe run of 14 Nov 2026 moved the fair value from $396.15 to $405.70 (+2.4%). The stock's own trading multiple rose with its price, and the fair value follows it in part: most of the move.
What the model makes of itThe price of $412.02 is 1.5% above it: Fairly valued, on a medium evidence grade.
What's nextReports on 20 Jan 2027. Options prices imply a move of about 10% either way over the next month. The next weekly run is on Saturday 21 Nov 2026.
What price range does the model give UNH?
The calibrated range for UNH over 63 trading days is $369.21 to $462.34. It sits around the last close, and its width comes from the volatility that UNH's own options imply (33% a year), calibrated weekly against realised prices (n = 8,038 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon. The fair value is the model's opinion and rides beside the range. It is not the centre of it.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $333.81 to $484.34. In 49% of the simulations the fair value came out above the price the model ran on.
Faircurve Insights · 14 Nov 2026
UnitedHealth Group Incorporated (UNH) is a comprehensive healthcare enterprise across the United States, with four divisions: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx.
Faircurve's model put the fair value at $405.70 a share on 14 Nov 2026, the midpoint of 2,000 simulations. The previous run, on 7 Nov 2026, gave $396.15, so the fair value moved +2.4%. In the model's words, "The stock's own trading multiple rose with its price, and the fair value follows it in part: most of the move." The calibrated range over 63 trading days is $369.21 to $462.34. Ranges built this way held the price 60% of the time at this horizon. The evidence grade is Medium. It looks at input completeness, the number of comparable companies and how closely they agree, and the spread of outcomes. It does not say whether the fair value is right.
The model's overall quality score is 64 out of 100, a composite of six factors scored against comparable companies. Earnings quality stands out at 93, with free cash flow to net income of 1.44x against a peer median of 0.44x. Profitability scores 76, with ROIC of 13.1% against a peer median of 10.1%. Stability scores 36, with five-year EBITDA margin downside volatility of 1.5 points against a peer median of 0.8 points. The comparable companies are CVS Health Corp. (CVS), Elevance Health Inc. (ELV), Cigna Corporation (CI), Humana Inc. (HUM), Centene Corp. (CNC), Molina Healthcare, Inc. (MOH) and Progyny, Inc. (PGNY).
Written from the figures on this page for the 14 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
The Global Pulse
Faircurve's note after each US session, in your inbox. No account needed.
When does UNH report earnings, and how has the stock reacted?
UnitedHealth Group's next earnings report is scheduled for 20 Jan 2027. Companies can move their dates.
Options prices on 16 Nov 2026 imply a move of about 4.5% in either direction through the nearest expiry, about 10 days out. That is the size the market is pricing, not a direction. UNH's 30 day implied volatility works out to about 9.6% over one month.
Around its last 8 reports: what the options market priced, and what followed
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across UNH's last 8 reports, ignoring direction, was 5.1%.
What the options market has priced for a month's move in UNH
How does UNH score on business quality?
UnitedHealth Group's overall quality score is 64 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 76 | 13.1%ROIC | 10.1% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 93 | 1.44xFCF / net income | 0.44x |
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analysts' rating changes. | 48 | 11.8%Revenue growth, trailing | 11.7% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 38 | 2.7%Net buybacks / market value | 2.8% |
| Balance sheetNet debt to EBITDA and interest coverage. | 58 | 1.73xNet debt / EBITDA | 2.24x |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 36 | 1.5 ptsEBITDA margin downside volatility, 5y | 0.8 pts |
How does UNH compare with similar companies?
The companies in healthcare plans closest to UnitedHealth Group in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| CVS CVS Health Corp. | $88.59 | $89.93 | +1.5% | Fairly valued |
| ELV Elevance Health Inc. | $446.28 | $454.75 | +1.9% | Fairly valued |
| CI Cigna Corporation | $300.16 | $384.76 | +28.2% | Undervalued |
| HUM Humana Inc. | $461.25 | $411.63 | -10.8% | Fairly valued |
| CNC Centene Corp. | $74.77 | $86.49 | +15.7% | Undervalued |
| MOH Molina Healthcare, Inc. | $233.09 | $227.64 | -2.3% | Fairly valued |
| PGNY Progyny, Inc. | $37.15 | $34.78 | -6.4% | Fairly valued |
What the comparable companies' multiples alone would give for UNH, the peer-implied price, is $400.62 a share on this run. The fair value weighs that against the company's own multiple.
UnitedHealth Group at a glance
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.
- Market value
- $365.1B
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Revenue expected, next twelve months
- $461.3B
- Consensus revenue growth, next fiscal year
- +0.2%
- Analysts with estimates
- 18
- Beta to the US market
- 0.32
- First valued by Faircurve
- 1 May 2026
At the close of 16 Nov 2026, 56.8% of the 1,085 graded US stocks the model covers traded below the model's fair value. UNH was not among them.
How the fair value is worked out: the model prices UnitedHealth Group on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 7 Nov 2026 the model's fair value for UNH was $396.15. As of 14 Nov 2026 it is $405.70, a change of +2.4%. The stock's own trading multiple rose with its price, and the fair value follows it in part: most of the move. The model revalues every stock it covers each week, and again after an earnings report.
Questions about UnitedHealth Group's valuation
Is UnitedHealth Group stock undervalued or overvalued?
On Faircurve's model, UNH reads as Fairly valued as of 14 Nov 2026. The model's fair value is $405.70 a share against a last close of $412.02, a gap of -1.5%.
What is UNH's fair value?
$405.70 a share as of 14 Nov 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $333.81 to $484.34.
What price range does the model give UNH?
$369.21 to $462.34 over 63 trading days. Ranges built this way held the price 60% of the time across 8,038 past valuations, refreshed 14 Nov 2026.
When does UnitedHealth Group report earnings next?
The next report is scheduled for 20 Jan 2027. Companies can move their dates.
How much has UNH moved on past earnings reports?
Across its last 8 reports the median two session move was 5.1%, ignoring direction. The largest was -27.3% around the report of 17 Apr 2025.
How confident is the model in this valuation?
The model's evidence grade for UNH is medium. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.
The model's own ideas on UNH
The model holds no idea open on UNH today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on UNH with their outcomes. A free account is enough.